S. Collot

858 total citations
18 papers, 154 citations indexed

About

S. Collot is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, S. Collot has authored 18 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in S. Collot's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). S. Collot is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Systemic Sclerosis and Related Diseases (3 papers). S. Collot collaborates with scholars based in France, Canada and Luxembourg. S. Collot's co-authors include Grégoire Prévôt, Julien Mazières, A. Didier, Myriam Delaunay, Laurent Guilleminault, Audrey Rabeau, Isabelle Rouquette, Emilie Bousquet, Nicolás Meyer and Fatima‐Zohra Mokrane and has published in prestigious journals such as Annals of Oncology, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

S. Collot

16 papers receiving 152 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Collot France 7 83 81 19 18 18 18 154
T. De Greslan France 7 73 0.9× 55 0.7× 32 1.7× 18 1.0× 9 0.5× 27 187
Chiaki Hosoda Japan 7 47 0.6× 115 1.4× 17 0.9× 7 0.4× 54 3.0× 18 163
Kinnosuke Matsumoto Japan 7 53 0.6× 65 0.8× 16 0.8× 10 0.6× 7 0.4× 20 109
Laura Moi Switzerland 6 34 0.4× 35 0.4× 17 0.9× 9 0.5× 8 0.4× 15 122
Yasuhiko Suga Japan 6 34 0.4× 32 0.4× 10 0.5× 11 0.6× 9 0.5× 13 86
Alessia Comes Italy 7 85 1.0× 157 1.9× 6 0.3× 22 1.2× 35 1.9× 12 220
Miljan Folić Serbia 6 44 0.5× 39 0.5× 10 0.5× 10 0.6× 19 1.1× 22 124
Sae Wada Japan 8 56 0.7× 130 1.6× 16 0.8× 13 0.7× 3 0.2× 23 180
Daniela Petrò Italy 6 64 0.8× 11 0.1× 30 1.6× 24 1.3× 7 0.4× 9 125
J.L. Bessich United States 7 36 0.4× 197 2.4× 4 0.2× 19 1.1× 10 0.6× 15 237

Countries citing papers authored by S. Collot

Since Specialization
Citations

This map shows the geographic impact of S. Collot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Collot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Collot more than expected).

Fields of papers citing papers by S. Collot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Collot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Collot. The network helps show where S. Collot may publish in the future.

Co-authorship network of co-authors of S. Collot

This figure shows the co-authorship network connecting the top 25 collaborators of S. Collot. A scholar is included among the top collaborators of S. Collot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Collot. S. Collot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Hermant, C., Gavin Plat, Magali Colombat, et al.. (2024). Real-time and non-invasive acute lung rejection diagnosis using confocal LASER Endomicroscopy in lung transplant recipients: Results from the CELTICS study. Pulmonology. 31(1). 2416795–2416795. 3 indexed citations
3.
Faguer, Stanislas, et al.. (2023). HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up. Seminars in Arthritis and Rheumatism. 63. 152307–152307. 4 indexed citations
4.
Dupuis, Marion, S. Pontier, S. Collot, et al.. (2023). Impact of bronchoscopic lung volume reduction with endobronchial valves on dynamic hyperinflation: Results from the PIERCE study. Respirology. 28(6). 525–532. 2 indexed citations
5.
Pugnet, G., S. Collot, Philippe Otal, et al.. (2022). Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation. Lara D. Veeken. 62(SI). SI32–SI42. 6 indexed citations
6.
7.
Egenod, Thomas, Jérémy Tricard, S. Collot, et al.. (2021). Two-Stage Bronchoscopic Endobronchial Valve Treatment Can Lead to Progressive Lung Volume Reduction and May Decrease Pneumothorax Risk. International Journal of COPD. Volume 16. 1957–1965. 6 indexed citations
8.
Prévôt, Grégoire, et al.. (2021). EPIDemio : épidémiologie des pneumopathies interstitielles diffuses (PID) fibrosantes en Haute-Garonne. Revue des Maladies Respiratoires. 38(10). 972–979. 1 indexed citations
9.
Lepage, Benoît, Laurent Mhanna, S. Pontier, et al.. (2021). Severe SARS-CoV-2 pneumonia: Clinical, functional and imaging outcomes at 4 months. Respiratory Medicine and Research. 80. 100822–100822. 19 indexed citations
10.
Guibert, Nicolas, S. Collot, P Fajadet, et al.. (2020). Confocal LASER endomicroscopy in Niemann–Pick disease type B. European Respiratory Journal. 57(2). 2002306–2002306. 1 indexed citations
11.
Prévôt, Grégoire, Magali Colombat, S. Collot, et al.. (2020). Diffuse alveolar haemorrhage secondary to e-cigarette “vaping” associated lung injury (EVALI) in a young European consumer. European Respiratory Journal. 56(1). 2000143–2000143. 7 indexed citations
12.
Dimeglio, Chloé, S. Collot, Florence Abravanel, et al.. (2020). Diagnosis options in patients suffering from COVID‐19‐like symptoms. Journal of Medical Virology. 93(7). 4076–4077. 1 indexed citations
13.
Delaunay, Myriam, Grégoire Prévôt, S. Collot, et al.. (2019). Management of pulmonary toxicity associated with immune checkpoint inhibitors. European Respiratory Review. 28(154). 190012–190012. 63 indexed citations
14.
Bousquet, Emilie, Audrey Rabeau, Isabelle Rouquette, et al.. (2018). Granulomatose sarcoïdosique survenant sous inhibiteurs de point de contrôle immunitaire. Revue des Maladies Respiratoires. 35(9). 963–967. 17 indexed citations
15.
Mazières, Julien, Fabrice Barlési, Bruno Coudert, et al.. (2018). OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial.. Journal of Thoracic Oncology. 13(10). S348–S349. 7 indexed citations
16.
Mazières, Julien, Fabrice Barlési, Xavier Quantin, et al.. (2018). Vemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial. Annals of Oncology. 29. viii538–viii539.
17.
Delaunay, Myriam, Philippe Caron, V. Sibaud, et al.. (2018). Toxicité des inhibiteurs de points de contrôle immunitaires. Revue des Maladies Respiratoires. 35(10). 1028–1038. 11 indexed citations
18.
Mokrane, Fatima‐Zohra, S. Collot, V. Chabbert, et al.. (2015). Hemostastic embolization in oncology. Diagnostic and Interventional Imaging. 96(7-8). 807–821. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. De Greslan Breakdown of academic impact, for papers by Chiaki Hosoda Breakdown of academic impact, for papers by Kinnosuke Matsumoto Breakdown of academic impact, for papers by Laura Moi Breakdown of academic impact, for papers by Yasuhiko Suga Breakdown of academic impact, for papers by Alessia Comes Breakdown of academic impact, for papers by Miljan Folić Breakdown of academic impact, for papers by Sae Wada Breakdown of academic impact, for papers by Daniela Petrò Breakdown of academic impact, for papers by J.L. Bessich
Rankless by CCL
2026